EVALUATION OF THE NEW CONTROL IQ TECHNOLOGY SYSTEM IN 36 TYPE 1 DIABETES PATIENTS USING SENSOR AUGMENTED LOW GLUCOSE SUSPEND PUMP

被引：0
|
作者：
Dominguez-Lopez, M. [1 ]
Vallejo Mora, R. [1 ]
Perez Salas, P. [1 ]
Soria Utrilla, V. [1 ]
Ruiz De Adana, M. [1 ]
机构：
[1] Hosp Reg Malaga, Endocrinol, Malaga, Spain
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP033 / #6
引用
收藏
页码：A93 / A94
页数：2
相关论文
共 50 条
  • [1] The Effectiveness of Sensor-Augmented Pump Therapy with Automatic Low-Glucose Suspend in Japanese Patients with Type 1 Diabetes
    Tsunemi, Asako
    Sato, Junko
    Kurita, Mika
    Wakabayashi, Yuka
    Waseda, Naoko
    Koshibu, Mami
    Shinohara, Mai
    Ozaki, Atsuko
    Nakamura, Hiromi
    Hirano, Naomi
    Ikeda, Fuki
    Watada, Hirotaka
    DIABETES, 2019, 68
  • [2] FACTORS ASSOCIATED WITH CLINICALLY SIGNIFICANT HYPOGLYCEMIA IN PATIENTS WITH TYPE 1 DIABETES USING SUSPEND-BEFORE-LOW SENSOR AUGMENTED PUMP TECHNOLOGY
    Gomez, A. M.
    Henao, D.
    Imitola, A.
    Grassi Corrales, B.
    Conget, I.
    Gimenez, M.
    Vinals, C.
    Martin, R.
    Garcia Jaramillo, M.
    Leon-Vargas, F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A171 - A172
  • [3] Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT
    Benhalima, Katrien
    van Nes, Falco
    Laenen, Annouschka
    Gillard, Pieter
    Mathieu, Chantal
    DIABETOLOGIA, 2021, 64 (12) : 2725 - 2730
  • [4] Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared to low glucose suspend: a crossover RCT
    Benhalima, K.
    van Nes, F.
    Gillard, P.
    Mathieu, C.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 179 - 179
  • [5] Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT
    Katrien Benhalima
    Falco van Nes
    Annouschka Laenen
    Pieter Gillard
    Chantal Mathieu
    Diabetologia, 2021, 64 : 2725 - 2730
  • [6] Sensor Augmented Patch Pump with Predictive Low Glucose Suspend Feature in Elderly Patients with Brittle Diabetes
    Hacisahinogullari, H.
    Caklili, O. Telci
    Cakmak, R.
    Yilmaz, M.
    Sarar, S. Tekin
    Gurkan, E.
    Sahin, I.
    Yilmaz, M. T.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [7] Sensor-Augmented Insulin Pump with Predictive Low-Glucose Suspend (PLGS): Determining Optimal Settings of Pump and Sensor in a Multicenter Cohort of Patients with Type 1 Diabetes
    Michael Joubert
    Anaïs R. Briant
    Laurence Kessler
    Fatéma Fall-Mostaine
    Severine Dubois
    Bruno Guerci
    Laurène Schoumacker-Ley
    Yves Reznik
    Jean-Jacques Parienti
    Diabetes Therapy, 2022, 13 : 1645 - 1657
  • [8] Sensor-Augmented Insulin Pump with Predictive Low-Glucose Suspend (PLGS): Determining Optimal Settings of Pump and Sensor in a Multicenter Cohort of Patients with Type 1 Diabetes
    Joubert, Michael
    Briant, Anais R.
    Kessler, Laurence
    Fall-Mostaine, Fatema
    Dubois, Severine
    Guerci, Bruno
    Schoumacker-Ley, Laurene
    Reznik, Yves
    Parienti, Jean-Jacques
    DIABETES THERAPY, 2022, 13 (09) : 1645 - 1657
  • [9] Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes
    Maria Gomez, Ana
    Marin Carrillo, Lisseth Fernanda
    Munoz Velandia, Oscar Mauricio
    Rondon Sepulveda, Martin Alonso
    Arevalo Correa, Carol M.
    Mora Garzon, Edwin
    Cuervo Diaz, Maria Camila
    Henao Carrillo, Diana Cristina
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (02) : 109 - 114
  • [10] LONG TERM FOLLOW-UP OF SENSOR - AUGMENTED PUMP THERAPY WITH LOW GLUCOSE SUSPEND FUNCTION IN TYPE 1 DIABETES PATIENTS WITH HIGH RISK OF HYPOGLYCEMIA
    Gomez, A. M.
    Marin, L.
    Mora, E.
    Henao, D.
    Arevalo, C.
    Munoz, O.
    Rondoen, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A21 - A21
12345